311
Participants
Start Date
February 29, 2012
Primary Completion Date
June 30, 2020
Study Completion Date
June 30, 2020
BBI503
Virginia Cancer Specialists, P.C., Fairfax
Virginia Oncology Associates, Norfolk
Institute for Translational Oncology Research, Greenville Hospital System, Greenville
Indiana University, Indianapolis
University of Michigan Comprehensive Cancer Center, Ann Arbor
Mayo Clinic Cancer Center, Rochester, Rochester
Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
Texas Oncology- Tyler, Tyler
Texas Oncology- Fort Worth, Fort Worth
Cancer Care Centers of South Texas, San Antonio
Cancer Care Centers of South Texas - HOAST, San Antonio
Rocky Mountain Cancer Centers, Denver
Mayo Clinic Cancer Center, Scottsdale, Scottsdale
Comprehensive Cancer Centers of Nevada, Las Vegas
Yakima Memorial Hostpial/North Star Lodge, Yakima
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston
Ottawa Hospital Cancer Centre, Ottawa
Sumitomo Pharma America, Inc.
INDUSTRY